Exabis Library
Welcome to the e-CCO Library!
P561: Impact of ustekinumab TDM on clinical practice: a multi-centre, prospective, cross-sectional observational trial—mUST-Decide
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P561: Risk of stoma formation in patients with Crohn's perianal fistulas over a two decades period. A cohort study from a tertiary referral center.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P561: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and Mayo Endoscopic Score (MES) in predicting the therapeutic effect of mesalazine in UC patients.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P562 5-ASA in ulcerative colitis: Are they really needed in the biological therapy era?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P562: A Phase 1 Study Evaluating the Effect of Coadministration of Etrasimod on the Pharmacokinetics and Pharmacodynamics of a Monophasic Oral Contraceptive in Healthy Female Volunteers
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P562: Real world effectiveness and safety of ozanimod: One-year follow-up from a large tertiary center
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P562: Real-life infliximab trough levels among inflammatory bowel disease patients on maintenance therapy: should we redefine therapeutic range based on inflammatory load?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P562: Role, efficacy and safety of budesonide multi-matrix in ulcerative colitis in real life: A study in three Italian third-level centres
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P562: Treatment of older inflammatory bowel disease patients; steroid use and escalation to steroid sparing therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P562: Web-based questionnaire survey about self-management for patients with Inflammatory Bowel Disease in Japan
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P563 Shared decision-making in pregnancy in inflammatory bowel disease: Design of a pregnancy in IBD decision aid (PIDA)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P563: Association between smoking status and the efficacy and safety of tofacitinib in patients with Ulcerative Colitis: Data from the tofacitinib clinical programme
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P563: Comparison of long-term outcomes of infliximab with adalimumab in biologic naïve patients with Crohn’s disease: a tertiary referral center 13-year experience.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P563: Monitoring of vedolizumab drug levels in a treat to target strategy for moderate-severe IBD (MOVE-IBD)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P563: Psychotherapy experience and demand for it and their association in inflammatory bowel disease – results from an internet-based survey
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P563: Stopping anti-TNFα monotherapy in Crohn's disease patients in deep remission and favourable disease characteristics is associated with a high rate of relapse
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P563: Thiopurine adverse events in patients with inflammatory bowel disease in the UK: inflammatory bowel disease BioResource cohort
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P564 Psychological acceptance of surgery in patients with inflammatory bowel disease undergoing intestinal resection
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P564: A qualitative exploration of acceptability of long-term use of oral nutritional supplement drinks as partial enteral nutrition in adolescent and adult Crohn's Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P564: Indigo naturalis induces mucosal healing in patients with ulcerative colitis: A multicentre randomised controlled trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM